| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biotechnology | 10 | 2012 | 57 | 2.730 |
Why?
|
| Cerebellar Neoplasms | 19 | 2025 | 315 | 2.650 |
Why?
|
| Medulloblastoma | 19 | 2025 | 379 | 2.640 |
Why?
|
| Bacteria | 13 | 2012 | 502 | 2.310 |
Why?
|
| Paracentesis | 4 | 2014 | 19 | 1.160 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 7 | 2016 | 134 | 1.090 |
Why?
|
| Pleural Effusion | 5 | 2014 | 106 | 1.050 |
Why?
|
| Bacterial Proteins | 14 | 2013 | 908 | 0.940 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 664 | 0.860 |
Why?
|
| Critical Care | 4 | 2018 | 661 | 0.840 |
Why?
|
| Intensive Care Units | 6 | 2021 | 490 | 0.840 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2013 | 192 | 0.760 |
Why?
|
| Consciousness Disorders | 1 | 2021 | 26 | 0.710 |
Why?
|
| Fungi | 2 | 2011 | 58 | 0.640 |
Why?
|
| Chylothorax | 2 | 2018 | 26 | 0.630 |
Why?
|
| Respiratory Insufficiency | 4 | 2018 | 237 | 0.610 |
Why?
|
| Neuromuscular Blocking Agents | 2 | 2016 | 8 | 0.610 |
Why?
|
| Environmental Microbiology | 2 | 2009 | 14 | 0.600 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2025 | 1936 | 0.600 |
Why?
|
| Ependymoma | 4 | 2024 | 139 | 0.590 |
Why?
|
| Babesiosis | 1 | 2018 | 2 | 0.580 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2018 | 15 | 0.570 |
Why?
|
| Neoplastic Stem Cells | 3 | 2025 | 331 | 0.570 |
Why?
|
| Pulmonary Fibrosis | 4 | 2008 | 110 | 0.560 |
Why?
|
| Time Management | 1 | 2018 | 8 | 0.560 |
Why?
|
| Hedgehog Proteins | 4 | 2025 | 197 | 0.560 |
Why?
|
| Point-of-Care Systems | 3 | 2019 | 194 | 0.540 |
Why?
|
| Medical Staff, Hospital | 1 | 2018 | 92 | 0.530 |
Why?
|
| Esophagectomy | 1 | 2018 | 64 | 0.520 |
Why?
|
| Gastrectomy | 1 | 2018 | 98 | 0.520 |
Why?
|
| Pseudomonas putida | 4 | 2013 | 6 | 0.520 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2018 | 77 | 0.520 |
Why?
|
| Betacoronavirus | 1 | 2020 | 282 | 0.520 |
Why?
|
| Multiple Organ Failure | 1 | 2018 | 144 | 0.510 |
Why?
|
| Humans | 77 | 2025 | 126089 | 0.500 |
Why?
|
| Inpatients | 1 | 2020 | 539 | 0.480 |
Why?
|
| Enzymes | 3 | 2011 | 43 | 0.480 |
Why?
|
| Piperazines | 2 | 2009 | 250 | 0.480 |
Why?
|
| Critical Care Nursing | 1 | 2015 | 5 | 0.480 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 359 | 0.460 |
Why?
|
| Antineoplastic Agents | 3 | 2011 | 1757 | 0.460 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 372 | 0.460 |
Why?
|
| Lung Diseases | 2 | 2017 | 392 | 0.450 |
Why?
|
| Lung | 7 | 2014 | 1519 | 0.450 |
Why?
|
| Pneumothorax | 3 | 2019 | 82 | 0.440 |
Why?
|
| Public Health Administration | 1 | 2014 | 9 | 0.430 |
Why?
|
| O Antigens | 6 | 2005 | 11 | 0.430 |
Why?
|
| Pyrimidines | 2 | 2009 | 403 | 0.430 |
Why?
|
| Metagenome | 3 | 2012 | 141 | 0.420 |
Why?
|
| Biosensing Techniques | 2 | 2011 | 70 | 0.420 |
Why?
|
| Pseudomonas aeruginosa | 6 | 2005 | 170 | 0.420 |
Why?
|
| Esophageal Neoplasms | 1 | 2018 | 371 | 0.410 |
Why?
|
| Epigastric Arteries | 1 | 2013 | 6 | 0.400 |
Why?
|
| Hemoperitoneum | 1 | 2013 | 9 | 0.400 |
Why?
|
| Meningeal Neoplasms | 2 | 2025 | 175 | 0.400 |
Why?
|
| Thrombosis | 1 | 2018 | 501 | 0.400 |
Why?
|
| Pandemics | 1 | 2020 | 1132 | 0.390 |
Why?
|
| Shock, Hemorrhagic | 1 | 2013 | 51 | 0.390 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 168 | 0.380 |
Why?
|
| Vascular Neoplasms | 1 | 2012 | 32 | 0.380 |
Why?
|
| Lung Diseases, Interstitial | 5 | 2018 | 174 | 0.380 |
Why?
|
| Aged | 26 | 2021 | 20005 | 0.370 |
Why?
|
| Dyspnea | 3 | 2014 | 130 | 0.370 |
Why?
|
| Salmonella Vaccines | 1 | 2011 | 7 | 0.370 |
Why?
|
| Salmonella | 1 | 2011 | 30 | 0.360 |
Why?
|
| Clinical Competence | 4 | 2016 | 1018 | 0.360 |
Why?
|
| Fatal Outcome | 4 | 2021 | 357 | 0.360 |
Why?
|
| Salmonella Infections | 1 | 2011 | 31 | 0.360 |
Why?
|
| Transcriptome | 4 | 2025 | 1061 | 0.360 |
Why?
|
| Biofilms | 2 | 2010 | 93 | 0.350 |
Why?
|
| Isotope Labeling | 1 | 2011 | 93 | 0.350 |
Why?
|
| Anti-Bacterial Agents | 5 | 2012 | 2495 | 0.350 |
Why?
|
| Shigella flexneri | 3 | 2003 | 16 | 0.350 |
Why?
|
| Research | 2 | 2010 | 253 | 0.340 |
Why?
|
| Membrane Transport Proteins | 2 | 2009 | 173 | 0.340 |
Why?
|
| Lung Neoplasms | 4 | 2014 | 1494 | 0.340 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2012 | 152 | 0.340 |
Why?
|
| Shiga Toxin | 1 | 2010 | 2 | 0.330 |
Why?
|
| DNA, Bacterial | 3 | 2013 | 484 | 0.330 |
Why?
|
| Infratentorial Neoplasms | 3 | 2024 | 33 | 0.330 |
Why?
|
| Mutagenicity Tests | 1 | 2010 | 20 | 0.330 |
Why?
|
| Biofuels | 1 | 2010 | 10 | 0.330 |
Why?
|
| Meningococcal Vaccines | 1 | 2010 | 30 | 0.330 |
Why?
|
| Middle Aged | 26 | 2021 | 27331 | 0.320 |
Why?
|
| Brain Neoplasms | 5 | 2024 | 1224 | 0.320 |
Why?
|
| Cryptogenic Organizing Pneumonia | 2 | 2007 | 4 | 0.320 |
Why?
|
| Repressor Proteins | 3 | 2022 | 762 | 0.320 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2012 | 380 | 0.320 |
Why?
|
| Male | 35 | 2024 | 62089 | 0.320 |
Why?
|
| Protein Engineering | 1 | 2010 | 60 | 0.310 |
Why?
|
| Microarray Analysis | 1 | 2010 | 224 | 0.310 |
Why?
|
| Ecosystem | 1 | 2010 | 108 | 0.310 |
Why?
|
| Ultrasonography | 2 | 2014 | 935 | 0.310 |
Why?
|
| Metencephalon | 3 | 2025 | 11 | 0.310 |
Why?
|
| Gastrointestinal Tract | 1 | 2011 | 218 | 0.300 |
Why?
|
| Microbiology | 1 | 2009 | 7 | 0.300 |
Why?
|
| Biological Products | 1 | 2011 | 136 | 0.300 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2025 | 1231 | 0.290 |
Why?
|
| Pericarditis, Constrictive | 1 | 2008 | 6 | 0.290 |
Why?
|
| Otx Transcription Factors | 2 | 2025 | 25 | 0.290 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2018 | 331 | 0.290 |
Why?
|
| Gene Expression Profiling | 5 | 2025 | 1763 | 0.280 |
Why?
|
| Communicable Diseases | 1 | 2010 | 153 | 0.280 |
Why?
|
| Medicine | 1 | 2009 | 100 | 0.280 |
Why?
|
| Benchmarking | 1 | 2008 | 129 | 0.280 |
Why?
|
| Energy Metabolism | 2 | 2009 | 763 | 0.270 |
Why?
|
| Biomarkers, Tumor | 4 | 2025 | 1559 | 0.270 |
Why?
|
| Carcinoid Tumor | 1 | 2007 | 24 | 0.260 |
Why?
|
| Mutation | 12 | 2025 | 5926 | 0.250 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2007 | 31 | 0.250 |
Why?
|
| Genomics | 7 | 2025 | 1571 | 0.250 |
Why?
|
| Postoperative Complications | 2 | 2018 | 2968 | 0.250 |
Why?
|
| Retrospective Studies | 21 | 2024 | 16770 | 0.250 |
Why?
|
| Bacterial Infections | 1 | 2009 | 308 | 0.250 |
Why?
|
| Radiopharmaceuticals | 1 | 2007 | 159 | 0.240 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2007 | 121 | 0.240 |
Why?
|
| Female | 33 | 2025 | 67915 | 0.240 |
Why?
|
| Cause of Death | 1 | 2008 | 473 | 0.240 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2025 | 22 | 0.230 |
Why?
|
| Radiation Tolerance | 1 | 2025 | 58 | 0.230 |
Why?
|
| Dioxygenases | 1 | 2025 | 66 | 0.230 |
Why?
|
| Meninges | 1 | 2025 | 20 | 0.230 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 576 | 0.230 |
Why?
|
| Shab Potassium Channels | 1 | 2025 | 6 | 0.230 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2025 | 20 | 0.230 |
Why?
|
| Legionella pneumophila | 2 | 2016 | 6 | 0.230 |
Why?
|
| Positron-Emission Tomography | 1 | 2007 | 291 | 0.220 |
Why?
|
| Bleomycin | 1 | 2004 | 110 | 0.220 |
Why?
|
| Mice | 15 | 2025 | 17585 | 0.220 |
Why?
|
| Cell Plasticity | 1 | 2025 | 36 | 0.220 |
Why?
|
| Animals | 20 | 2025 | 33120 | 0.220 |
Why?
|
| Transforming Growth Factor beta | 2 | 2018 | 447 | 0.210 |
Why?
|
| Respiration, Artificial | 4 | 2019 | 486 | 0.210 |
Why?
|
| Tumor Microenvironment | 2 | 2025 | 626 | 0.210 |
Why?
|
| DNA Copy Number Variations | 3 | 2025 | 1003 | 0.200 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2007 | 316 | 0.200 |
Why?
|
| DNA Methylation | 3 | 2025 | 1036 | 0.200 |
Why?
|
| Ultrasonography, Interventional | 2 | 2019 | 199 | 0.200 |
Why?
|
| Lipid A | 1 | 2002 | 23 | 0.200 |
Why?
|
| Hematologic Neoplasms | 1 | 2006 | 294 | 0.190 |
Why?
|
| Biopsy | 8 | 2014 | 1234 | 0.190 |
Why?
|
| Immunity, Innate | 1 | 2025 | 394 | 0.190 |
Why?
|
| Telemedicine | 2 | 2020 | 486 | 0.190 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2024 | 276 | 0.190 |
Why?
|
| Gene Expression Regulation, Bacterial | 5 | 2013 | 167 | 0.190 |
Why?
|
| Publication Bias | 1 | 2002 | 15 | 0.190 |
Why?
|
| Neoplasms | 2 | 2021 | 2848 | 0.190 |
Why?
|
| Genes, Bacterial | 1 | 2002 | 216 | 0.180 |
Why?
|
| Cell Proliferation | 6 | 2025 | 2389 | 0.180 |
Why?
|
| Adult | 14 | 2021 | 30254 | 0.180 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2021 | 4 | 0.180 |
Why?
|
| Methemoglobinemia | 1 | 2021 | 9 | 0.180 |
Why?
|
| Information Storage and Retrieval | 1 | 2002 | 62 | 0.180 |
Why?
|
| Hospital Mortality | 5 | 2021 | 976 | 0.180 |
Why?
|
| Transcription Factors | 4 | 2025 | 2341 | 0.170 |
Why?
|
| Glasgow Coma Scale | 1 | 2021 | 195 | 0.170 |
Why?
|
| Neurologic Examination | 1 | 2021 | 192 | 0.170 |
Why?
|
| Genetic Complementation Test | 4 | 2010 | 86 | 0.170 |
Why?
|
| Aged, 80 and over | 10 | 2021 | 6552 | 0.170 |
Why?
|
| Internal Medicine | 1 | 2002 | 127 | 0.170 |
Why?
|
| Hypertriglyceridemia | 1 | 2021 | 114 | 0.160 |
Why?
|
| Pancreatitis | 1 | 2021 | 137 | 0.160 |
Why?
|
| Transferases | 1 | 2000 | 4 | 0.160 |
Why?
|
| Cerebrospinal Fluid | 1 | 2020 | 93 | 0.160 |
Why?
|
| Diagnosis, Differential | 7 | 2014 | 1845 | 0.160 |
Why?
|
| Cell Line, Tumor | 5 | 2025 | 3483 | 0.160 |
Why?
|
| Health Facilities | 1 | 2020 | 67 | 0.160 |
Why?
|
| Bioelectric Energy Sources | 2 | 2009 | 2 | 0.160 |
Why?
|
| Hexosyltransferases | 2 | 2001 | 7 | 0.160 |
Why?
|
| RNA, Small Nuclear | 1 | 2019 | 41 | 0.160 |
Why?
|
| Thoracentesis | 1 | 2019 | 9 | 0.150 |
Why?
|
| Thoracostomy | 1 | 2019 | 26 | 0.150 |
Why?
|
| Fatty Liver | 1 | 2021 | 204 | 0.150 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 686 | 0.150 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 199 | 0.150 |
Why?
|
| Enoxaparin | 1 | 2018 | 41 | 0.150 |
Why?
|
| Babesia microti | 1 | 2018 | 2 | 0.140 |
Why?
|
| Quinine | 1 | 2018 | 8 | 0.140 |
Why?
|
| Quinidine | 1 | 2018 | 10 | 0.140 |
Why?
|
| Cancer Vaccines | 1 | 2020 | 188 | 0.140 |
Why?
|
| Clindamycin | 1 | 2018 | 39 | 0.140 |
Why?
|
| Immunocompetence | 1 | 2018 | 30 | 0.140 |
Why?
|
| Factor Xa Inhibitors | 1 | 2018 | 47 | 0.140 |
Why?
|
| Radiography, Thoracic | 2 | 2017 | 146 | 0.140 |
Why?
|
| Antiprotozoal Agents | 1 | 2018 | 34 | 0.140 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 33 | 0.140 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2018 | 34 | 0.140 |
Why?
|
| Disease Progression | 5 | 2025 | 2099 | 0.140 |
Why?
|
| Plasma Exchange | 1 | 2018 | 82 | 0.140 |
Why?
|
| Organizational Innovation | 1 | 2018 | 44 | 0.140 |
Why?
|
| Signal Transduction | 6 | 2025 | 4468 | 0.140 |
Why?
|
| Data Display | 1 | 2017 | 13 | 0.140 |
Why?
|
| Mortality | 1 | 2019 | 249 | 0.140 |
Why?
|
| Imatinib Mesylate | 2 | 2009 | 47 | 0.140 |
Why?
|
| Comorbidity | 3 | 2014 | 1538 | 0.130 |
Why?
|
| Oxycodone | 1 | 2017 | 14 | 0.130 |
Why?
|
| Critical Illness | 3 | 2017 | 603 | 0.130 |
Why?
|
| Confusion | 1 | 2017 | 16 | 0.130 |
Why?
|
| Sleep Apnea, Central | 1 | 2017 | 10 | 0.130 |
Why?
|
| Precision Medicine | 2 | 2018 | 344 | 0.130 |
Why?
|
| Sepsis | 1 | 2021 | 490 | 0.130 |
Why?
|
| Omalizumab | 1 | 2017 | 36 | 0.130 |
Why?
|
| Heart Arrest | 1 | 2021 | 359 | 0.130 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 135 | 0.130 |
Why?
|
| Benzamides | 2 | 2009 | 120 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2025 | 930 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2017 | 143 | 0.130 |
Why?
|
| Cough | 1 | 2017 | 94 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 252 | 0.130 |
Why?
|
| Risk Factors | 5 | 2018 | 10397 | 0.120 |
Why?
|
| Patient Transfer | 1 | 2017 | 107 | 0.120 |
Why?
|
| Biotransformation | 3 | 2013 | 53 | 0.120 |
Why?
|
| beta-Galactosidase | 3 | 2010 | 134 | 0.120 |
Why?
|
| Aldehyde-Lyases | 1 | 2016 | 5 | 0.120 |
Why?
|
| Empyema, Pleural | 1 | 2016 | 25 | 0.120 |
Why?
|
| Follow-Up Studies | 6 | 2014 | 5050 | 0.120 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2016 | 9 | 0.120 |
Why?
|
| Cohort Studies | 6 | 2019 | 4920 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 4 | 2013 | 721 | 0.120 |
Why?
|
| Sphingolipids | 1 | 2016 | 33 | 0.120 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2017 | 118 | 0.120 |
Why?
|
| Evolution, Molecular | 1 | 2019 | 683 | 0.120 |
Why?
|
| Respiratory Function Tests | 3 | 2014 | 207 | 0.120 |
Why?
|
| Fetus | 1 | 2019 | 578 | 0.120 |
Why?
|
| Laryngoscopy | 1 | 2017 | 157 | 0.120 |
Why?
|
| Treatment Outcome | 6 | 2020 | 12328 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2022 | 1849 | 0.120 |
Why?
|
| Embryonic Structures | 2 | 2025 | 8 | 0.110 |
Why?
|
| Echocardiography | 2 | 2012 | 1098 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 973 | 0.110 |
Why?
|
| Manometry | 1 | 2014 | 71 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 380 | 0.110 |
Why?
|
| Health Care Surveys | 1 | 2015 | 279 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 1378 | 0.110 |
Why?
|
| Iatrogenic Disease | 2 | 2019 | 120 | 0.110 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1025 | 0.110 |
Why?
|
| Chest Pain | 1 | 2014 | 93 | 0.110 |
Why?
|
| Minnesota | 3 | 2009 | 172 | 0.100 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2017 | 220 | 0.100 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2013 | 13 | 0.100 |
Why?
|
| Radiography | 2 | 2006 | 749 | 0.100 |
Why?
|
| Operon | 1 | 2013 | 48 | 0.100 |
Why?
|
| Pneumonia | 1 | 2017 | 333 | 0.100 |
Why?
|
| Bronchoscopy | 4 | 2008 | 176 | 0.100 |
Why?
|
| Hospitalization | 2 | 2019 | 1838 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 859 | 0.100 |
Why?
|
| Anti-Infective Agents | 1 | 2016 | 260 | 0.100 |
Why?
|
| Escherichia coli | 3 | 2010 | 962 | 0.100 |
Why?
|
| Biodegradation, Environmental | 2 | 2010 | 12 | 0.100 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2014 | 100 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2018 | 1011 | 0.100 |
Why?
|
| Health Resources | 1 | 2014 | 126 | 0.100 |
Why?
|
| Blood Vessels | 1 | 2013 | 98 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2015 | 273 | 0.100 |
Why?
|
| Multimedia | 1 | 2012 | 11 | 0.100 |
Why?
|
| Autophagy | 1 | 2016 | 404 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2017 | 6093 | 0.090 |
Why?
|
| Abdomen | 1 | 2013 | 131 | 0.090 |
Why?
|
| Bronchi | 3 | 2010 | 102 | 0.090 |
Why?
|
| Calorimetry | 2 | 2009 | 63 | 0.090 |
Why?
|
| Tertiary Care Centers | 3 | 2019 | 246 | 0.090 |
Why?
|
| Genome, Bacterial | 1 | 2013 | 209 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2000 | 1568 | 0.090 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 1293 | 0.090 |
Why?
|
| Cost of Illness | 1 | 2014 | 283 | 0.090 |
Why?
|
| Adaptation, Physiological | 2 | 2013 | 259 | 0.090 |
Why?
|
| Molecular Sequence Data | 5 | 2013 | 3599 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2002 | 1194 | 0.090 |
Why?
|
| Enzyme Stability | 1 | 2011 | 56 | 0.090 |
Why?
|
| Directed Molecular Evolution | 1 | 2011 | 11 | 0.090 |
Why?
|
| Cold Temperature | 1 | 2011 | 81 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2013 | 256 | 0.090 |
Why?
|
| Chromatography, Liquid | 2 | 2024 | 231 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2014 | 2026 | 0.090 |
Why?
|
| Cross-Linking Reagents | 2 | 2002 | 50 | 0.090 |
Why?
|
| Child | 9 | 2024 | 25062 | 0.090 |
Why?
|
| Pulmonary Edema | 2 | 2014 | 55 | 0.090 |
Why?
|
| Genetic Heterogeneity | 2 | 2025 | 129 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2014 | 423 | 0.090 |
Why?
|
| Acute Disease | 3 | 2016 | 1046 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2018 | 871 | 0.090 |
Why?
|
| Carbon Isotopes | 1 | 2011 | 230 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 693 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2005 | 298 | 0.090 |
Why?
|
| Mediastinoscopy | 1 | 2010 | 6 | 0.090 |
Why?
|
| End Stage Liver Disease | 1 | 2013 | 184 | 0.080 |
Why?
|
| Organisms, Genetically Modified | 1 | 2010 | 11 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 615 | 0.080 |
Why?
|
| Kinetics | 2 | 2010 | 1090 | 0.080 |
Why?
|
| Endosonography | 1 | 2010 | 78 | 0.080 |
Why?
|
| Hair Dyes | 1 | 2010 | 1 | 0.080 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2010 | 105 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2014 | 1476 | 0.080 |
Why?
|
| Laccase | 1 | 2010 | 4 | 0.080 |
Why?
|
| Quinic Acid | 1 | 2010 | 2 | 0.080 |
Why?
|
| Caproates | 1 | 2010 | 6 | 0.080 |
Why?
|
| Ribose | 1 | 2010 | 11 | 0.080 |
Why?
|
| Time Factors | 5 | 2019 | 6016 | 0.080 |
Why?
|
| Sulfur | 1 | 2010 | 11 | 0.080 |
Why?
|
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2010 | 7 | 0.080 |
Why?
|
| Phenethylamines | 1 | 2010 | 15 | 0.080 |
Why?
|
| Succinic Acid | 1 | 2010 | 13 | 0.080 |
Why?
|
| Drug Resistance, Multiple | 1 | 2010 | 54 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 3649 | 0.080 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2010 | 36 | 0.080 |
Why?
|
| Salicylates | 1 | 2010 | 54 | 0.080 |
Why?
|
| Palliative Care | 1 | 2014 | 438 | 0.080 |
Why?
|
| Binding Sites | 2 | 2010 | 1187 | 0.080 |
Why?
|
| Viscosity | 1 | 2010 | 39 | 0.080 |
Why?
|
| Peroxidase | 1 | 2010 | 60 | 0.080 |
Why?
|
| Tyramine | 1 | 2009 | 2 | 0.080 |
Why?
|
| Laccaria | 1 | 2009 | 1 | 0.080 |
Why?
|
| Hematoma, Subdural | 1 | 2009 | 25 | 0.080 |
Why?
|
| Phenylethyl Alcohol | 1 | 2010 | 30 | 0.080 |
Why?
|
| Pest Control, Biological | 1 | 2009 | 18 | 0.080 |
Why?
|
| Methane | 1 | 2009 | 18 | 0.080 |
Why?
|
| Asthma | 1 | 2017 | 758 | 0.080 |
Why?
|
| Elasticity | 1 | 2010 | 93 | 0.080 |
Why?
|
| Nitrogen | 1 | 2010 | 122 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2004 | 1014 | 0.080 |
Why?
|
| Membrane Lipids | 1 | 2009 | 31 | 0.080 |
Why?
|
| Leukopenia | 1 | 2009 | 43 | 0.080 |
Why?
|
| Soil Microbiology | 1 | 2009 | 18 | 0.080 |
Why?
|
| Climate | 1 | 2009 | 23 | 0.080 |
Why?
|
| Valine | 1 | 2010 | 110 | 0.080 |
Why?
|
| Carbon | 1 | 2010 | 88 | 0.080 |
Why?
|
| Fructose | 1 | 2010 | 60 | 0.080 |
Why?
|
| Amino Acid Sequence | 4 | 2005 | 2544 | 0.080 |
Why?
|
| beta-Lactams | 1 | 2009 | 57 | 0.080 |
Why?
|
| Prednisone | 2 | 2008 | 239 | 0.080 |
Why?
|
| Metals | 1 | 2009 | 56 | 0.080 |
Why?
|
| Single-Cell Analysis | 2 | 2025 | 317 | 0.080 |
Why?
|
| Bacterial Vaccines | 1 | 2009 | 103 | 0.070 |
Why?
|
| Biological Transport, Active | 1 | 2009 | 73 | 0.070 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2009 | 67 | 0.070 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 313 | 0.070 |
Why?
|
| Ligands | 1 | 2010 | 477 | 0.070 |
Why?
|
| Plant Roots | 1 | 2008 | 30 | 0.070 |
Why?
|
| Infant | 5 | 2024 | 12762 | 0.070 |
Why?
|
| Pericardiectomy | 1 | 2008 | 10 | 0.070 |
Why?
|
| Gastroesophageal Reflux | 2 | 2014 | 323 | 0.070 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2008 | 73 | 0.070 |
Why?
|
| Plants | 1 | 2008 | 43 | 0.070 |
Why?
|
| Protein Binding | 2 | 2010 | 1661 | 0.070 |
Why?
|
| Environmental Pollutants | 1 | 2009 | 72 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2010 | 2029 | 0.070 |
Why?
|
| Bacteriophages | 1 | 2009 | 86 | 0.070 |
Why?
|
| Biological Evolution | 1 | 2009 | 233 | 0.070 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2008 | 55 | 0.070 |
Why?
|
| Virulence Factors | 1 | 2009 | 169 | 0.070 |
Why?
|
| Pulmonary Medicine | 1 | 2008 | 30 | 0.070 |
Why?
|
| Acetyltransferases | 2 | 2005 | 72 | 0.070 |
Why?
|
| Biomarkers | 3 | 2014 | 3138 | 0.070 |
Why?
|
| Autopsy | 1 | 2008 | 112 | 0.070 |
Why?
|
| Inflammation | 2 | 2025 | 1418 | 0.070 |
Why?
|
| Models, Molecular | 3 | 2018 | 1054 | 0.070 |
Why?
|
| Glucocorticoids | 2 | 2008 | 339 | 0.070 |
Why?
|
| Operator Regions, Genetic | 1 | 2007 | 4 | 0.070 |
Why?
|
| Cerebellum | 2 | 2022 | 414 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 1735 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2011 | 1227 | 0.070 |
Why?
|
| Gene Regulatory Networks | 2 | 2021 | 360 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2010 | 744 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 1281 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2009 | 355 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2009 | 351 | 0.070 |
Why?
|
| Epigenomics | 2 | 2020 | 175 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2009 | 395 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2025 | 3706 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 1002 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2009 | 790 | 0.060 |
Why?
|
| Risk | 1 | 2008 | 726 | 0.060 |
Why?
|
| Linear Models | 2 | 2021 | 673 | 0.060 |
Why?
|
| Metabolome | 1 | 2009 | 316 | 0.060 |
Why?
|
| Length of Stay | 3 | 2017 | 1324 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 1207 | 0.060 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2006 | 8 | 0.060 |
Why?
|
| Protein Structure, Secondary | 3 | 2005 | 237 | 0.060 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2007 | 354 | 0.060 |
Why?
|
| Immunosuppressive Agents | 2 | 2008 | 650 | 0.060 |
Why?
|
| Cluster Analysis | 2 | 2017 | 410 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2009 | 336 | 0.060 |
Why?
|
| Alkaptonuria | 1 | 2005 | 3 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2009 | 1574 | 0.060 |
Why?
|
| Anemia | 1 | 2009 | 336 | 0.060 |
Why?
|
| Pneumoconiosis | 1 | 2005 | 1 | 0.060 |
Why?
|
| Uronic Acids | 1 | 2005 | 4 | 0.060 |
Why?
|
| Child, Preschool | 5 | 2021 | 14329 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2008 | 365 | 0.060 |
Why?
|
| Serotyping | 2 | 2002 | 171 | 0.060 |
Why?
|
| Carbon-Oxygen Ligases | 1 | 2005 | 1 | 0.060 |
Why?
|
| Proteomics | 1 | 2009 | 563 | 0.060 |
Why?
|
| Causality | 1 | 2005 | 89 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2025 | 27 | 0.060 |
Why?
|
| Prognosis | 3 | 2025 | 4709 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2025 | 42 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 1096 | 0.060 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2006 | 124 | 0.060 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2004 | 11 | 0.060 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2004 | 18 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2004 | 12 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2002 | 261 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2004 | 93 | 0.060 |
Why?
|
| Carbohydrate Dehydrogenases | 1 | 2004 | 3 | 0.060 |
Why?
|
| Dimerization | 2 | 2007 | 135 | 0.060 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2004 | 46 | 0.060 |
Why?
|
| Luciferases | 1 | 2004 | 125 | 0.060 |
Why?
|
| Blood-Brain Barrier | 1 | 2025 | 139 | 0.050 |
Why?
|
| Recurrence | 1 | 2008 | 1400 | 0.050 |
Why?
|
| Fibronectins | 1 | 2004 | 99 | 0.050 |
Why?
|
| Plasmids | 3 | 2005 | 445 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 187 | 0.050 |
Why?
|
| Heart Failure | 1 | 2017 | 2175 | 0.050 |
Why?
|
| Quality of Life | 1 | 2014 | 2023 | 0.050 |
Why?
|
| Stem Cell Niche | 1 | 2024 | 57 | 0.050 |
Why?
|
| Infrared Rays | 1 | 2024 | 21 | 0.050 |
Why?
|
| Scleroderma, Systemic | 1 | 2005 | 126 | 0.050 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2006 | 277 | 0.050 |
Why?
|
| Rhombencephalon | 1 | 2024 | 57 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2025 | 567 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2024 | 229 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2025 | 151 | 0.050 |
Why?
|
| Proline | 2 | 2004 | 76 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 330 | 0.050 |
Why?
|
| Lasers | 1 | 2024 | 107 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2025 | 285 | 0.050 |
Why?
|
| beta-Lactamases | 1 | 2005 | 210 | 0.050 |
Why?
|
| Leukemia | 1 | 2006 | 356 | 0.050 |
Why?
|
| Collagen | 1 | 2004 | 293 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2002 | 136 | 0.050 |
Why?
|
| Lymphoma | 1 | 2006 | 319 | 0.050 |
Why?
|
| Fibrosis | 1 | 2004 | 398 | 0.050 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2022 | 5 | 0.050 |
Why?
|
| Base Sequence | 3 | 2007 | 2770 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 100 | 0.050 |
Why?
|
| Phenotype | 2 | 2010 | 4304 | 0.050 |
Why?
|
| Salmonella typhimurium | 2 | 1999 | 42 | 0.050 |
Why?
|
| Lung Transplantation | 1 | 2006 | 344 | 0.050 |
Why?
|
| Histone Demethylases | 1 | 2022 | 37 | 0.050 |
Why?
|
| Connective Tissue Diseases | 2 | 2016 | 29 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 742 | 0.050 |
Why?
|
| Controlled Before-After Studies | 1 | 2021 | 2 | 0.050 |
Why?
|
| Sentinel Surveillance | 1 | 2021 | 21 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2022 | 111 | 0.050 |
Why?
|
| Chromatin | 1 | 2025 | 477 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2006 | 487 | 0.040 |
Why?
|
| Patient Care Bundles | 1 | 2021 | 23 | 0.040 |
Why?
|
| Laser Capture Microdissection | 1 | 2021 | 8 | 0.040 |
Why?
|
| Lysogeny | 1 | 2001 | 9 | 0.040 |
Why?
|
| Lac Operon | 2 | 1998 | 90 | 0.040 |
Why?
|
| Pseudomonas Phages | 1 | 2001 | 9 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2022 | 323 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2024 | 505 | 0.040 |
Why?
|
| Feedback | 1 | 2021 | 149 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2004 | 820 | 0.040 |
Why?
|
| Injections, Intraventricular | 1 | 2020 | 55 | 0.040 |
Why?
|
| Adolescent | 4 | 2021 | 19936 | 0.040 |
Why?
|
| Microscopy | 1 | 2021 | 121 | 0.040 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 1730 | 0.040 |
Why?
|
| Shock, Septic | 1 | 2021 | 147 | 0.040 |
Why?
|
| Succinimides | 1 | 1999 | 7 | 0.040 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2000 | 65 | 0.040 |
Why?
|
| Immune Sera | 1 | 1999 | 83 | 0.040 |
Why?
|
| APACHE | 1 | 2019 | 50 | 0.040 |
Why?
|
| Stem Cells | 1 | 2024 | 676 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 1886 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 397 | 0.040 |
Why?
|
| Lysine | 1 | 2020 | 173 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2005 | 1486 | 0.040 |
Why?
|
| Formaldehyde | 1 | 1999 | 36 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 90 | 0.040 |
Why?
|
| Cell Line | 2 | 2020 | 2565 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2004 | 2902 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 1999 | 284 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 205 | 0.040 |
Why?
|
| Cytokines | 1 | 2004 | 1312 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 622 | 0.040 |
Why?
|
| Artificial Gene Fusion | 1 | 1998 | 11 | 0.040 |
Why?
|
| Glycine | 1 | 1999 | 161 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 985 | 0.040 |
Why?
|
| Snail Family Transcription Factors | 1 | 2018 | 25 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2019 | 231 | 0.040 |
Why?
|
| Codon | 1 | 1998 | 96 | 0.040 |
Why?
|
| Neuroectodermal Tumors | 1 | 2018 | 12 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 1998 | 92 | 0.040 |
Why?
|
| Organ Dysfunction Scores | 1 | 2018 | 52 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1998 | 78 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2018 | 63 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2019 | 298 | 0.030 |
Why?
|
| Rhabdoid Tumor | 1 | 2018 | 46 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2018 | 96 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 769 | 0.030 |
Why?
|
| Young Adult | 3 | 2021 | 9616 | 0.030 |
Why?
|
| Genome, Human | 1 | 2024 | 1281 | 0.030 |
Why?
|
| Melitten | 1 | 1997 | 3 | 0.030 |
Why?
|
| Regulon | 1 | 1997 | 9 | 0.030 |
Why?
|
| Typhoid Fever | 1 | 1997 | 18 | 0.030 |
Why?
|
| Salmonella typhi | 1 | 1997 | 21 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2017 | 92 | 0.030 |
Why?
|
| Teratoma | 1 | 2018 | 120 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 987 | 0.030 |
Why?
|
| Histones | 1 | 2020 | 505 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 148 | 0.030 |
Why?
|
| Legionnaires' Disease | 1 | 2016 | 8 | 0.030 |
Why?
|
| Total Lung Capacity | 1 | 2016 | 12 | 0.030 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2016 | 8 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 417 | 0.030 |
Why?
|
| Safety | 1 | 2016 | 208 | 0.030 |
Why?
|
| Hypercapnia | 1 | 2016 | 22 | 0.030 |
Why?
|
| Nurse Practitioners | 1 | 2016 | 47 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2016 | 78 | 0.030 |
Why?
|
| Pharmacists | 1 | 2016 | 102 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 987 | 0.030 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2015 | 18 | 0.030 |
Why?
|
| Physician Assistants | 1 | 2016 | 80 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2016 | 153 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 565 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2016 | 164 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 2936 | 0.030 |
Why?
|
| Computer Simulation | 1 | 1998 | 664 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 357 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 4409 | 0.030 |
Why?
|
| Glioma | 1 | 2019 | 478 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 847 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 1225 | 0.030 |
Why?
|
| Pressure | 1 | 2014 | 123 | 0.030 |
Why?
|
| Blood Sedimentation | 1 | 2014 | 26 | 0.030 |
Why?
|
| PubMed | 1 | 2014 | 22 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2021 | 1520 | 0.030 |
Why?
|
| Hypoxia | 1 | 2016 | 243 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2016 | 799 | 0.030 |
Why?
|
| Acanthamoeba castellanii | 1 | 2013 | 1 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2014 | 122 | 0.030 |
Why?
|
| RNA, Bacterial | 1 | 2013 | 53 | 0.030 |
Why?
|
| Genetic Fitness | 1 | 2013 | 30 | 0.030 |
Why?
|
| Cricetinae | 2 | 2004 | 365 | 0.030 |
Why?
|
| Survival Rate | 2 | 2009 | 2060 | 0.030 |
Why?
|
| Emphysema | 1 | 2014 | 62 | 0.030 |
Why?
|
| Drainage | 1 | 2014 | 249 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 708 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2017 | 682 | 0.020 |
Why?
|
| Circadian Clocks | 1 | 2013 | 82 | 0.020 |
Why?
|
| Knowledge | 1 | 2012 | 48 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2012 | 105 | 0.020 |
Why?
|
| Biodiversity | 1 | 2012 | 82 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1708 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2018 | 1060 | 0.020 |
Why?
|
| Phylogeny | 1 | 2013 | 719 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4496 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2005 | 786 | 0.020 |
Why?
|
| Physicians | 1 | 2016 | 618 | 0.020 |
Why?
|
| Virulence | 2 | 2003 | 264 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 1538 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 424 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 443 | 0.020 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2009 | 5 | 0.020 |
Why?
|
| Exudates and Transudates | 1 | 2009 | 16 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 424 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2009 | 64 | 0.020 |
Why?
|
| Azathioprine | 1 | 2008 | 37 | 0.020 |
Why?
|
| Pediatrics | 1 | 2018 | 1202 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2750 | 0.020 |
Why?
|
| Respiratory Care Units | 1 | 2007 | 2 | 0.020 |
Why?
|
| Tidal Volume | 1 | 2007 | 41 | 0.020 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2007 | 9 | 0.020 |
Why?
|
| DNA Footprinting | 1 | 2007 | 13 | 0.020 |
Why?
|
| Ultracentrifugation | 1 | 2007 | 21 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2009 | 320 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 53 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2009 | 354 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3256 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 3905 | 0.020 |
Why?
|
| Neutrophils | 1 | 2009 | 350 | 0.020 |
Why?
|
| Triglycerides | 1 | 2009 | 597 | 0.020 |
Why?
|
| Cholesterol | 1 | 2009 | 538 | 0.020 |
Why?
|
| United States | 2 | 2014 | 11204 | 0.020 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2005 | 14 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2007 | 146 | 0.010 |
Why?
|
| Acetyl Coenzyme A | 1 | 2005 | 14 | 0.010 |
Why?
|
| Locomotion | 1 | 2005 | 59 | 0.010 |
Why?
|
| Cell Wall | 1 | 2005 | 41 | 0.010 |
Why?
|
| Bacterial Adhesion | 1 | 2005 | 101 | 0.010 |
Why?
|
| Respiratory Mucosa | 1 | 2005 | 97 | 0.010 |
Why?
|
| Iodides | 1 | 2004 | 8 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 2004 | 55 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 2004 | 75 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2004 | 78 | 0.010 |
Why?
|
| Electrophoresis, Capillary | 1 | 2004 | 11 | 0.010 |
Why?
|
| Biopolymers | 1 | 2004 | 19 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2004 | 79 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2004 | 42 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 588 | 0.010 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2004 | 72 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 292 | 0.010 |
Why?
|
| Contrast Media | 1 | 2007 | 461 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 565 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 307 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2875 | 0.010 |
Why?
|
| Protein Folding | 1 | 2004 | 214 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2004 | 202 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2005 | 511 | 0.010 |
Why?
|
| Proteins | 1 | 2009 | 1015 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2004 | 334 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 602 | 0.010 |
Why?
|
| Dysentery, Bacillary | 1 | 2003 | 11 | 0.010 |
Why?
|
| Keratoconjunctivitis | 1 | 2003 | 16 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2003 | 157 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 947 | 0.010 |
Why?
|
| Prevalence | 1 | 2009 | 2579 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2003 | 412 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2004 | 449 | 0.010 |
Why?
|
| Arginine | 1 | 2004 | 335 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 768 | 0.010 |
Why?
|
| Incidence | 1 | 2009 | 3213 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2009 | 876 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2003 | 685 | 0.010 |
Why?
|
| DNA Polymerase I | 1 | 2001 | 10 | 0.010 |
Why?
|
| Actins | 1 | 2003 | 311 | 0.010 |
Why?
|
| Peptides | 1 | 2004 | 828 | 0.010 |
Why?
|
| Protamines | 1 | 1997 | 12 | 0.010 |
Why?
|
| Conjugation, Genetic | 1 | 1997 | 7 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1997 | 207 | 0.010 |
Why?
|
| Peritoneum | 1 | 1997 | 37 | 0.010 |
Why?
|
| Magnesium | 1 | 1997 | 118 | 0.010 |
Why?
|
| Biological Assay | 1 | 1997 | 104 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1997 | 180 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 1997 | 283 | 0.010 |
Why?
|
| Spleen | 1 | 1997 | 251 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1997 | 421 | 0.010 |
Why?
|